Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparisons Of Inflammatory Biomarkers And Cardiovascular Risk Scores Before And After Conversion To Full Dose Myfortic® Using Two Hour Neoral® Monitoring.

NCT02058875 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT02058875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02058875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparisons Of Inflammatory Biomarkers And Cardiovascular Risk Scores Before And After Conversion To Full Dose Myfortic® Using Two Hour Neoral® Monitoring.
Lead sponsor
University of Saskatchewan
Phase
Phase 4
Overall status
Withdrawn
Start date
February 28, 2014
Completion date
October 31, 2015
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, cardiovascular outcomes, kidney transplant recipients, kidney transplantation